
Avid Bioservices Investor Relations Material
Latest events

Q1 2025
Avid Bioservices
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avid Bioservices Inc
Access all reports
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO) that provides specialized services for the biotechnology and biopharmaceutical industries. The company focuses on biologics, offering process development, clinical and commercial Current Good Manufacturing Practice (CGMP) manufacturing, and related services. These include bulk packaging, release and stability testing, regulatory support, upstream and downstream process optimization, analytical methods development, and cell line development. Avid supports projects from early preclinical stages to commercial-scale production. Its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CDMO
Country
🇺🇸 United States